ASP Isotopes Inc. (NASDAQ:ASPI) Major Shareholder Ak Jensen Investment Managemen Acquires 70,000 Shares

ASP Isotopes Inc. (NASDAQ:ASPIGet Free Report) major shareholder Ak Jensen Investment Managemen acquired 70,000 shares of ASP Isotopes stock in a transaction that occurred on Monday, July 8th. The shares were purchased at an average price of $3.05 per share, for a total transaction of $213,500.00. Following the transaction, the insider now directly owns 6,586,874 shares in the company, valued at $20,089,965.70. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Ak Jensen Investment Managemen also recently made the following trade(s):

  • On Wednesday, July 10th, Ak Jensen Investment Managemen bought 61,849 shares of ASP Isotopes stock. The shares were bought at an average cost of $3.40 per share, for a total transaction of $210,286.60.

ASP Isotopes Stock Up 14.9 %

Shares of NASDAQ:ASPI opened at $3.54 on Thursday. ASP Isotopes Inc. has a 1 year low of $0.57 and a 1 year high of $5.67. The company has a market capitalization of $183.23 million, a price-to-earnings ratio of -6.68 and a beta of 5.12. The business’s 50-day moving average is $3.98 and its 200-day moving average is $3.39. The company has a debt-to-equity ratio of 1.70, a current ratio of 3.57 and a quick ratio of 3.57.

ASP Isotopes (NASDAQ:ASPIGet Free Report) last issued its earnings results on Wednesday, May 15th. The company reported ($0.16) EPS for the quarter. The company had revenue of $0.84 million during the quarter. Equities research analysts predict that ASP Isotopes Inc. will post -0.11 earnings per share for the current year.

Analyst Ratings Changes

Separately, HC Wainwright boosted their price objective on ASP Isotopes from $5.25 to $5.50 and gave the company a “buy” rating in a research note on Wednesday, April 17th.

Get Our Latest Research Report on ASPI

Institutional Trading of ASP Isotopes

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Virtu Financial LLC increased its position in ASP Isotopes by 477.0% in the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock valued at $346,000 after buying an additional 69,176 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of ASP Isotopes by 479.1% in the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after acquiring an additional 844,705 shares in the last quarter. Rathbones Group PLC bought a new position in shares of ASP Isotopes in the fourth quarter valued at approximately $272,000. Finally, HTLF Bank bought a new position in shares of ASP Isotopes in the fourth quarter valued at approximately $141,000. 16.80% of the stock is owned by institutional investors.

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Further Reading

Insider Buying and Selling by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.